/AVTR

AVTR Stock - Avantor, Inc.

Q: What is the analyst price target for AVTR?

Analyst price target information is not currently available for AVTR.

Q: What is AVTR's market cap?

Market capitalization information is not currently available for AVTR.

Healthcare|Medical - Instruments & Supplies|NYSE

$12.60+2.61%

+$0.32 (+2.61%) • Jan 13

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+-10.7%upside

Target: $11.25

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for AVTR

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.93

52W High$23.32

52W Low$10.62

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$6.78B	$6.97B	$7.51B	$7.39B	$6.39B
Gross Profit	$2.28B	$2.36B	$2.60B	$2.50B	$2.08B
Gross Margin	33.6%	33.9%	34.6%	33.9%	32.5%
Operating Income	$1.08B	$696.40M	$1.13B	$972.20M	$706.80M
Net Income	$711.50M	$321.10M	$686.50M	$572.60M	$116.60M
Net Margin	10.5%	4.6%	9.1%	7.8%	1.8%
EPS	$1.05	$0.48	$1.02	$0.86	$0.09

Company Overview

Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Visit Website

Earnings History & Surprises

AVTR

Beat Rate

67%

Last 18 quarters

Avg Surprise

+4.7%

EPS vs Estimate

Beats / Misses

12/5

1 met exactly

Latest EPS

$0.22

Q4 2025

EPS Surprise History

Q1 24

+13.6%

$0.25vs$0.22

Q2 24

+9.5%

$0.22vs$0.20

Q3 24

+7.6%

$0.25vs$0.23

Q4 24

+2.1%

$0.26vs$0.25

Q1 25

+8.0%

$0.27vs$0.25

Q2 25

-0.6%

$0.23vs$0.23

Q3 25

-4.0%

$0.24vs$0.25

Q4 25

-2.1%

$0.22vs$0.22

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	Apr 23, 2026	—	—	—	—
Q1 2026	Feb 6, 2026	$0.21	—	—	—
Q4 2025	Oct 29, 2025	$0.22	$0.22	-2.1%	✗ MISS
Q3 2025	Aug 1, 2025	$0.25	$0.24	-4.0%	✗ MISS
Q2 2025	Apr 25, 2025	$0.23	$0.23	-0.6%	✗ MISS
Q1 2025	Feb 7, 2025	$0.25	$0.27	+8.0%	✓ BEAT
Q4 2024	Oct 25, 2024	$0.25	$0.26	+2.1%	✓ BEAT
Q3 2024	Jul 26, 2024	$0.23	$0.25	+7.6%	✓ BEAT
Q2 2024	Apr 26, 2024	$0.20	$0.22	+9.5%	✓ BEAT
Q1 2024	Feb 14, 2024	$0.22	$0.25	+13.6%	✓ BEAT
Q4 2023	Oct 27, 2023	$0.25	$0.25	0.0%	= MET
Q3 2023	Jul 28, 2023	$0.29	$0.28	-3.4%	✗ MISS
Q2 2023	Apr 28, 2023	$0.28	$0.29	+3.6%	✓ BEAT
Q1 2023	Feb 3, 2023	$0.30	$0.32	+6.7%	✓ BEAT
Q4 2022	Oct 28, 2022	$0.33	$0.34	+3.0%	✓ BEAT
Q3 2022	Jul 28, 2022	$0.38	$0.37	-2.6%	✗ MISS
Q2 2022	Apr 28, 2022	$0.35	$0.38	+8.6%	✓ BEAT
Q1 2022	Feb 3, 2022	$0.33	$0.36	+9.1%	✓ BEAT
Q4 2021	Oct 28, 2021	$0.32	$0.35	+9.4%	✓ BEAT
Q3 2021	Jul 29, 2021	$0.30	$0.35	+16.7%	✓ BEAT

Frequently Asked Questions about AVTR

What is AVTR's current stock price?

Avantor, Inc. (AVTR) is currently trading at $12.60 per share. The stock has moved +2.61% today.

What is the analyst price target for AVTR?

The average analyst price target for AVTR is $11.25, based on 1 analyst.

What sector is Avantor, Inc. in?

Avantor, Inc. operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the NYSE exchange.

What is AVTR's market cap?

Avantor, Inc. has a market capitalization of $8.59 billion, making it a mid-cap company.

Does AVTR pay dividends?

No, Avantor, Inc. does not currently pay a dividend to shareholders.